Kazutaka Nakamura, MD

Disclosure information not submitted.

Presentation(s):

• MP03-19: Association between immune-related Adverse Events and Survival of Patients with metastatic Urothelial Carcinoma Treated with Pembrolizumab

  Friday, May 13, 2022
  7:00 AM – 8:15 AM